Nutrition and prostate cancer: an overview

References

• Frattaroli J, Weidner G, Dnistrian AM, et al. Clinical events in prostate cancer lifestyle trial: results from two years of follow-up. Urology 2008;72(6):1319-23
   PubMedGoogle Scholar
• Ornish D, Weidner G, Fair WR, et al. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol 2005;174(3):1065-9
   PubMed Web of Science ®Google Scholar
• McDermott CL, Blough DK, Fedorenko CR, et al. Complementary and alternative medicine use among newly diagnosed prostate cancer patients. Support Care Cancer 2012;20(1):65-73
   PubMedGoogle Scholar
• Wilkinson S, Farrelly S, Low J, et al. The use of complementary therapy by men with prostate cancer in the UK. Eur J Cancer Care (Engl) 2008;17(5):492-9
   PubMedGoogle Scholar
• Szeto YT, Kwok TC, Benzie IF. Effects of a long-term vegetarian diet on biomarkers of antioxidant status and cardiovascular disease risk. Nutrition 2004;20(10):863-6
   PubMed Web of Science ®Google Scholar
• Rosato V, Edefonti V, Bravi F, et al. Nutrient-based dietary patterns and prostate cancer risk: a case–control study from Italy. Cancer Causes Control 2014;25(4):525-32
   PubMed Web of Science ®Google Scholar
• McGrowder DA, Jackson LA, Crawford TV. Prostate cancer and metabolic syndrome: is there a link? Asian Pac J Cancer Prev 2012;13(1):1-13
   PubMedGoogle Scholar
• MacInnis RJ, English DR. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 2006;17(8):989-1003
   PubMed Web of Science ®Google Scholar
• Hsing AW, Sakoda LC, Chua S Jr. Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr 2007;86(3):s843-57
   Web of Science ®Google Scholar
• Pelucchi C, Serraino D, Negri E, et al. The metabolic syndrome and risk of prostate cancer in Italy. Ann Epidemiol 2011;21(11):835-41
   PubMedGoogle Scholar
• Franz MJ. The role of nutrition therapy and dietitians in the management of the metabolic syndrome. Curr Diab Rep 2007;7(1):60-5
   PubMedGoogle Scholar
• Liu Y, Hu F, Li D, et al. Does physical activity reduce the risk of prostate cancer? A systematic review and meta-analysis. Eur Urol 2011;60(5):1029-44
   PubMed Web of Science ®Google Scholar
• Rebillard A, Lefeuvre-Orfila L, Gueritat J, Cillard J. Prostate cancer and physical activity: adaptive response to oxidative stress. Free Radic Biol Med 2013;60:115-24
   PubMed Web of Science ®Google Scholar
• Magbanua MJ, Richman EL, Sosa EV, et al. Physical activity and prostate gene expression in men with low-risk prostate cancer. Cancer Causes Control 2014;25(4):515-23
   PubMedGoogle Scholar
• Colli JL, Colli A. Comparisons of prostate cancer mortality rates with dietary practices in the United States. Urol Oncol 2005;23(6):390-8
   PubMedGoogle Scholar
• Chan JM, Gann PH, Giovannucci EL. Role of diet in prostate cancer development and progression. J Clin Oncol 2005;23(32):8152-60
   PubMed Web of Science ®Google Scholar
• Chavarro JE, Stampfer MJ, Hall MN, et al. A 22-y prospective study of fish intake in relation to prostate cancer incidence and mortality. Am J Clin Nutr 2008;88(5):1297-303
   PubMed Web of Science ®Google Scholar
• Epstein MM, Kasperzyk JL, Mucci LA, et al. Dietary fatty acid intake and prostate cancer survival in Örebro County. Sweden. Am J Epidemiol 2012;176(3):240-52
   PubMedGoogle Scholar
• Szymanski KM, Wheeler DC, Mucci LA. Fish consumption and prostate cancer risk: a review and meta-analysis. Am J Clin Nutr 2010;92(5):1223-33
   PubMed Web of Science ®Google Scholar
• McCarty MF, DiNicolantonio JJ, Lavie CJ, O’Keefe JH. Omega-3 and prostate cancer: examining the pertinent evidence. Mayo Clin Proc 2014;89(4):444-50
   PubMedGoogle Scholar
• Gu Z, Suburu J, Chen H, Chen YQ. Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention. Biomed Res Int 2013;2013:824563
   PubMed Web of Science ®Google Scholar
• Wang Z, Fan J, Liu M, et al. Nutraceuticals for prostate cancer chemoprevention: from molecular mechanisms to clinical application. Expert Opin Investig Drugs 2013;22(12):1613-26
   PubMed Web of Science ®Google Scholar
• van Breemen RB, Pajkovic N. Multitargeted therapy of cancer by lycopene. Cancer Lett 2008;269(2):339-51
   PubMed Web of Science ®Google Scholar
• Mordente A, Guantario B, Meucci E, et al. Lycopene and cardiovascular diseases: an update. Curr Med Chem 2011;18(8):1146-63
   PubMed Web of Science ®Google Scholar
• Brown MJ, Ferruzzi MG, Nguyen ML, et al. Carotenoid bioavailability is higher from salads ingested with full-fat than with fat-reduced salad dressings as measured with electrochemical detection. Am J Clin Nutr 2004;80(2):396-403
   PubMed Web of Science ®Google Scholar
• Etminan M, Takkouche B, Caamaño-Isorna F. The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev 2004;13(3):340-5
   PubMed Web of Science ®Google Scholar
• Obermüller-Jevic UC, Olano-Martin E, Corbacho AM, et al. Lycopene inhibits the growth of normal human prostate epithelial cells in vitro. J Nutr 2003;133(11):3356-60
   PubMedGoogle Scholar
• Zu K, Mucci L, Rosner BA, et al. Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era. J Natl Cancer Inst 2014;106(2):djt430
   PubMedGoogle Scholar
• Barnes S. The biochemistry, chemistry and physiology of the isoflavones in soybeans and their food products. Lymphat Res Biol 2010;8(1):89-98
   PubMed Web of Science ®Google Scholar
• Perabo FG, Von Löw EC, Ellinger J, et al. Soy isoflavone genistein in prevention and treatment of prostate cancer. Prostate Cancer Prostatic Dis 2008;11(1):6-12
   PubMed Web of Science ®Google Scholar
• Omoni AO, Aluko RE. Soybean foods and their benefits: potential mechanisms of action. Nutr Rev 2005;63(8):272-83
   PubMed Web of Science ®Google Scholar
• Rabiau N, Kossaï M, Braud M, et al. Genistein and daidzein act on a panel of genes implicated in cell cycle and angiogenesis by polymerase chain reaction arrays in human prostate cancer cell lines. Cancer Epidemiol 2010;34(2):200-6
   PubMed Web of Science ®Google Scholar
• Hwang YW, Kim SY, Jee SH, et al. Soy food consumption and risk of prostate cancer: a meta-analysis of observational studies. Nutr Cancer 2009;61(5):598-606
   PubMed Web of Science ®Google Scholar
• Maskarinec G, Morimoto Y, Hebshi S, et al. Serum prostate-specific antigen but not testosterone levels decrease in a randomized soy intervention among men. Eur J Clin Nutr 2006;60(12):1423-9
   PubMed Web of Science ®Google Scholar
• Hamilton-Reeves JM, Rebello SA, Thomas W, et al. Effects of soy protein isolate consumption on prostate cancer biomarkers in men with HGPIN, ASAP, and low-grade prostate cancer. Nutr Cancer 2008;60(1):7-13
   PubMedGoogle Scholar
• Ide H, Tokiwa S, Sakamaki K, et al. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen. Prostate 2010;70(10):1127-33
   PubMed Web of Science ®Google Scholar
• Dalais FS, Meliala A, Wattanapenpaiboon N, et al. Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer. Urology 2004;64(3):510-15
   PubMed Web of Science ®Google Scholar
• Hsu A, Bray TM, Helferich WG, et al. Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells. Exp Biol Med (Maywood) 2010;235(1):90-7
   PubMed Web of Science ®Google Scholar
• Viuda-Martos M, Fernandez-Lopez J, Perez-Alvarez JA. Pomegranate and its many functional components as related to human health: a review. Compr Rev Food Sci Food Saf 2010;9(6):635-54
   PubMed Web of Science ®Google Scholar
• Basu A, Penugonda K. Pomegranate juice: a heart-healthy fruit juice. Nutr Rev 2009;67(1):49-56
   PubMedGoogle Scholar
• Hong MY, Seeram NP, Heber D. Pomegranate polyphenols down-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptor. J Nutr Biochem 2008;19(12):848-55
   PubMedGoogle Scholar
• Lansky EP, Jiang W, Mo H, et al. Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. Invest New Drugs 2005;23(1):11-20
   PubMedGoogle Scholar
• Koyama S, Cobb LJ, Mehta HH, et al. Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF–IGFBP axis. Growth Horm IGF Res 2010;20(1):55-62
   PubMedGoogle Scholar
• Malik A, Afaq F, Sarfaraz S, et al. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci USA 2005;102(41):14813-18
   PubMed Web of Science ®Google Scholar
• Kasimsetty SG, Bialonska D, Reddy MK, et al. Effects of pomegranate chemical constituents/intestinal microbial metabolites on CYP1B1 in 22Rv1 prostate cancer cells. J Agric Food Chem 2009;57(22):10636-44
   PubMedGoogle Scholar
• Pantuck AJ, Leppert JT, Zomorodian N, et al. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res 2006;12(13):4018-26
   PubMed Web of Science ®Google Scholar
• Paller CJ, Ye X, Wozniak PJ, et al. A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer. Prostate Cancer Prostatic Dis 2013;16(1):50-5
   PubMedGoogle Scholar
• Yang CS, Wang H. Mechanistic issues concerning cancer prevention by tea catechins. Mol Nutr Food Res 2011;55(6):819-31
   PubMed Web of Science ®Google Scholar
• Sang S, Lambert JD, Ho C, et al. Green tea polyphenols. In: Encyclopedia of Dietary Supplements (2nd Edition). Coates PM, Betz JM, Blackman MR, et al. Eds.) Informa Healthcare; New York, NY: 2010. pp 402-10
   Google Scholar
• Deka A, Vita JA. Tea and cardiovascular disease. Pharmacol Res 2011;64(2):136-45
   PubMed Web of Science ®Google Scholar
• Yang CS, Wang H, Li GX, et al. Cancer prevention by tea: evidence from laboratory studies. Pharmacol Res 2011;64(2):113-22
   PubMedGoogle Scholar
• Zheng J, Yang B, Huang T, et al. Green tea and black tea consumption and prostate cancer risk: an exploratory meta-analysis of observational studies. Nutr Cancer 2011;63(5):663-72
   PubMed Web of Science ®Google Scholar
• Chuu CP, Chen RY, Kokontis JM, et al. Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells. Cancer Lett 2009;275(1):86-92
   PubMedGoogle Scholar
• Albrecht DS, Clubbs EA, Ferruzzi M, et al. Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation. Chem Biol Interact 2008;171(1):89-95
   PubMed Web of Science ®Google Scholar
• Thomas F, Holly JM, Persad R, et al. Green tea extract (epigallocatechin-3-gallate) reduces efficacy of radiotherapy on prostate cancer cells. Urology 2011;78(2):475.e15-21
   Google Scholar
• Kurahashi N, Sasazuki S, Iwasaki M, et al. Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol 2008;167:71-7
   PubMed Web of Science ®Google Scholar
• Bettuzzi S, Brausi M, Rizzi F, et al. Chemo prevention of human prostate cancer by Oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Canctr Res 2006;66:1234-40
   PubMed Web of Science ®Google Scholar
• Brausi M, Rizzi F, Bettuzri S. Chemoprevention of human prostate cancer by green tea catechins: two years later. a follow-up update. Eur Urol 2008;54:472-3
   PubMed Web of Science ®Google Scholar
• Jian L, Xie LP, Lee AH, Binns CW. Protective effect of green tea against prostate cancer: a case–control study in southeast China. Int J Cancer 2004;108:130-5
   PubMed Web of Science ®Google Scholar
• Choan E, Segal R, Jonker D, et al. A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach. Urol Oncol 2005;23:108-13
   PubMed Web of Science ®Google Scholar
• Brown KM, Arthur JR. Selenium, selenoproteins and human health: a review. Public Health Nutr 2001;4(2B):593-9
   PubMedGoogle Scholar
• Tanguy S, Grauzam S, de Leiris J, et al. Impact of dietary selenium intake on cardiac health: experimental approaches and human studies. Mol Nutr Food Res 2012;56(7):1106-21
   PubMed Web of Science ®Google Scholar
• Bodnar M, Konieczka P, Namiesnik J. The properties, functions, and use of selenium compounds in living organisms. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2012;30(3):225-52
   PubMedGoogle Scholar
• Lunøe K, Gabel-Jensen C, Stürup S, et al. Investigation of the selenium metabolism in cancer cell lines. Metallomics 2011;3(2):162-8
   PubMedGoogle Scholar
• Kong L, Yuan Q, Zhu H, et al. The suppression of prostate LNCaP cancer cells growth by selenium nanoparticles through Akt/Mdm2/AR controlled apoptosis. Biomaterials 2011;32(27):6515-22
   PubMed Web of Science ®Google Scholar
• Sarveswaran S, Liroff J, Zhou Z, et al. Selenite triggers rapid transcriptional activation of p53, and p53-mediated apoptosis in prostate cancer cells: implication for the treatment of early-stage prostate cancer. Int J Oncol 2010;36(6):1419-28
   PubMed Web of Science ®Google Scholar
• Chan JM, Oh WK, Xie W, et al. Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer. J Clin Oncol 2009;27(22):3577-83
   PubMed Web of Science ®Google Scholar
• Steinbrecher A, Méplan C, Hesketh J, et al. Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men. Cancer Epidemiol Biomarkers Prev 2010;19(11):2958-68
   PubMed Web of Science ®Google Scholar
• Klein EA. Selenium and vitamin E cancer prevention trial. Ann N Y Acad Sci 1031:234-41.2004
   PubMed Web of Science ®Google Scholar
• Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009;301(1):39-51
   PubMed Web of Science ®Google Scholar
• Klein EA, Thompson IM Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011;306(14):1549-56
   PubMed Web of Science ®Google Scholar
• Weinstein SJ, Peters U, Ahn J, et al. Serum α-tocopherol and γ-tocopherol concentrations and prostate cancer risk in the PLCO Screening Trial: a nested case–control study. PLoS One 2012;7(7):e40204
   Google Scholar
• Mateljan G. The World’s Healthiest Foods. 1st Edition). GMF Publishing; Canada: 2007. 780-1
   Google Scholar
• Mateljan G. The World’s Healthiest Foods. 1st Edition). GMF Publishing; Canada: 2007. 798-9
   Google Scholar
• Thomas R, Williams M, Sharma H, et al. A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer–the UK. NCRN Pomi-T study. Prostate Cancer Prostatic Dis 2014;17(2):180-6
   PubMed Web of Science ®Google Scholar
• Yan J, Xie B, Capodice JL, et al. Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutamide to inhibit prostate cancer cell growth. Prostate 2012;72(3):244-52
   PubMedGoogle Scholar
• Huang EC, Chen G, Baek SJ, et al. Zyflamend reduces the expression of androgen receptor in a model of castrate-resistant prostate cancer. Nutr Cancer 2011;63(8):1287-96
   PubMed Web of Science ®Google Scholar
• Capodice JL, Gorroochurn P, Cammack AS, et al. Zyflamend in men with high-grade prostatic intraepithelial neoplasia: results of a phase I clinical trial. J Soc Integr Oncol 2009;7(2):43-51
   PubMedGoogle Scholar
• Giudice A, Montella M. Activation of the Nrf2-ARE signaling pathway: a promising strategy in cancer prevention. Bioessays 2006;28(2):169-81
   PubMed Web of Science ®Google Scholar
• Speciale A, Chirafisi J, Saija A, Cimino F. Nutritional antioxidants and adaptive cell responses: an update. Curr Mol Med 2011;11(9):770-89
   PubMed Web of Science ®Google Scholar
• Nair S, Barve A, Khor TO, et al. Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforophane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells. Acta Pharmacol Sin 2010;31(9):1223-40
   PubMed Web of Science ®Google Scholar
• Palozza P, Catalano A, Simone R, Cittadini A. Lycopene as a guardian of redox signalling. Acta Biochim Pol 2012;59(1):21-5
   PubMedGoogle Scholar
• Zhai X, Lin M, Zhang F, et al. Dietary flavonoid genistein induces Nrf2 and phase II detoxification gene expression via ERKs and PKC pathways and protects against oxidative stress in Caco-2 cells. Mol Nutr Food Res 2013;57(2):249-59
   PubMed Web of Science ®Google Scholar
• Yang YC, Lii CK, Wei YL, et al. Docosahexaenoic acid inhibition of inflammation is partially via cross-talk between Nrf2/heme oxygenase 1 and IKK/NF-κB pathways. J Nutr Biochem 2013;24(1):204-12
   PubMedGoogle Scholar